1 past transactions

Plato BioPharma

Acquisition in 2021
Plato BioPharma is a world-class preclinical drug discovery CRO specializing in vivo physiological and pharmacological studies with complementary biochemical, biomarker and histology analysis in the cardiovascular, renal, pulmonary, diabetes, and hepatic therapeutic areas.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.